Install
Cell & Gene Therapies
CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up.
- 4 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Cell & Gene Therapies
Biomarker Could Predict Response to Low-Dose CAR T Cell Therapy
6+ min ago (410+ words) CD27-negative, CD39-negative CAR T cells were associated with treatment response when limited cell numbers were administered A distinct population of CAR T cells could help predict whether products containing fewer cells than intended will still produce a therapeutic response, according…...
Gene-editing treatment could transform high cholesterol care
2+ hour, 35+ min ago (16+ words) CBS News Gene-editing treatment could transform high cholesterol care...
Gene may serve as critical protector against coronary artery disease
9+ hour, 17+ min ago (664+ words) A gene previously linked to coronary artery disease risk appears to serve as a powerful protector of the heart’s arteries, according to researchers at the Medical College of Georgia at Augusta University. In a new study published in Circulation, researchers…...
NTLA: Late-stage gene editing therapies for HAE and TTR advance, with FDA review and strong market prospects
4+ hour, 58+ min ago (86+ words) TradingView NTLA: Late-stage gene editing therapies for HAE and TTR advance, with FDA review and strong market prospects The company is advancing in vivo gene editing with late-stage programs for HAE and TTR, expecting FDA approval for its HAE therapy…...
Forget Clearing Cholesterol—What If We Just Stopped Making It? | mindbodygreen
12+ hour, 45+ min ago (847+ words) If you've ever been told your cholesterol is too high, you've probably heard the same advice: take a statin, watch your diet, and let your body do the work of clearing out the "bad" cholesterol. For some people, that approach…...
News: CMN Moderates Panel Discussion at CSGCT 2026??? In Vivo CRISPR Medicine: From Scientific Promise to Patients at Scale
21+ hour, 49+ min ago (337+ words) CMN Moderates Panel Discussion at CSGCT 2026 – In Vivo CRISPR Medicine: From Scientific Promise to Patients at Scale CRISPR Medicine News CMN Moderates Panel Discussion at CSGCT 2026 – In Vivo CRISPR Medicine: From Scientific Promise to Patients at Scale CMN founder Jens-Ole…...
Exegenesis Bio, Modalis Partner to Advance CRISPR-Based DMD Therapy MDL-201
1+ day, 8+ hour ago (68+ words) 14 September 2026 | Monday | News The financial impact of this research collaboration on Modalis' results for the current fiscal year is expected to be immaterial, and there is no revision to the earnings forecast at this time. Two Chairs, 11,000 Kilometres Apart: The…...
Gene editing approach could provide lasting treatment for rare liver disease - study
1+ day, 22+ hour ago (270+ words) More than 500 different gene mutations can cause the disease, making mutation-specific treatments impractical. Researchers in Australia have developed a genome editing approach that could provide a more durable treatment for children with a rare genetic liver disorder. Researchers have taken…...
Aptamer-Guided CRISPR-Cas9 Delivery Could Make Cancer Genome Editing
1+ day, 20+ hour ago (55+ words) Gene editing has long promised a revolution in cancer medicine, yet the promise has remained stubbornly out of reach for one deceptively simple reason: getting the CRISPR-Cas9 machinery into tumor cells, and only tumor cells, is extraordinarily difficult. A new…...